Klebsiella pneumoniae triggers a cytotoxic effect on airway epithelial cells by Cano, Victoria et al.
BioMed CentralBMC Microbiology
ssOpen AcceResearch article
Klebsiella pneumoniae triggers a cytotoxic effect on airway epithelial 
cells
Victoria Cano1,2, David Moranta1,2, Enrique Llobet-Brossa1,2, 
José Antonio Bengoechea1,2,3,4 and Junkal Garmendia*1,2,3
Address: 1Fundación Caubet-CIMERA, Programa de Infección e Inmunidad, Recinto Hospital Joan March, carretera Sóller, km 12, 07110, Bunyola, 
Spain, 2Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Bunyola, Spain, 3Área Microbiología, Facultad de 
Biología, Universidad Illes Balears, Carretera Valldemossa, km 7.5, 07122, Palma de Mallorca, Spain and 4Consejo Superior de Investigaciones 
Científicas (CSIC), Madrid, Spain
Email: Victoria Cano - victoria.cano@caubet-cimera.es; David Moranta - david.moranta@caubet-cimera.es; Enrique Llobet-
Brossa - llobet@caubet-cimera.es; José Antonio Bengoechea - bengoechea@caubet-cimera.es; Junkal Garmendia* - garmendia@caubet-cimera.es
* Corresponding author    
Abstract
Background: Klebsiella pneumoniae is a capsulated Gram negative bacterial pathogen and a
frequent cause of nosocomial infections. Despite its clinical relevance, little is known about the
features of the interaction between K. pneumoniae and lung epithelial cells on a cellular level, neither
about the role of capsule polysaccharide, one of its best characterised virulence factors, in this
interaction.
Results: The interaction between Klebsiella pneumoniae and cultured airway epithelial cells was
analysed. K. pneumoniae infection triggered cytotoxicity, evident by cell rounding and detachment
from the substrate. This effect required the presence of live bacteria and of capsule polysaccharide,
since it was observed with isolates expressing different amounts of capsule and/or different
serotypes but not with non-capsulated bacteria. Cytotoxicity was analysed by lactate
dehydrogenase and formazan measurements, ethidium bromide uptake and analysis of DNA
integrity, obtaining consistent and complementary results. Moreover, cytotoxicity of non-
capsulated strains was restored by addition of purified capsule during infection. While a non-
capsulated strain was avirulent in a mouse infection model, capsulated K. pneumoniae isolates
displayed different degrees of virulence.
Conclusion: Our observations allocate a novel role to K. pneumoniae capsule in promotion of
cytotoxicity. Although this effect is likely to be associated with virulence, strains expressing
different capsule levels were not equally virulent. This fact suggests the existence of other bacterial
requirements for virulence, together with capsule polysaccharide.
Background
Klebsiella pneumoniae is the most common Gram-negative
bacterium causing community-acquired pneumonia and
up to 5% of community-acquired urinary tract infections
[1-3]. Community-acquired pneumonia is a very severe
illness with a rapid onset, and despite the availability of
an adequate antibiotic regimen, the outcome is often
fatal. The observed mortality rates are about 50% [4]. Cap-
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ride (LPS) and adhesins are virulence factors identified for
this pathogen. However, most of the studies have focused
on the role of CPS in Klebsiella virulence. Early studies sug-
gested that an extracellular toxic complex mainly com-
posed of CPS triggers extensive lung tissue damage [5,6]
and data indicate that there might be a correlation
between the production of this extracellular complex and
Klebsiella virulence [5,6]. Similar to CPSs from other path-
ogens, Klebsiella CPS is responsible for resistance to com-
plement mediated killing [7] and impedes adhesion to
and invasion of epithelial cells [8] by sterically preventing
receptor-target recognition of bacterial adhesins [9,10].
Recently we have demonstrated that CPS mediates resist-
ance to antimicrobial peptides (APs), trapping APs and
thus acting as a bacterial decoy [11,12].
Few studies have analysed cellular features of the interac-
tion between lung epithelium and K. pneumoniae, the role
of virulence factors such as CPS, and the relevance of this
interaction in vivo. We have recently shown that an iso-
genic CPS mutant activates host cellular inflammatory
responses and that CPS might prevent this activation
through blockage of bacterial uptake [13]. Moreover, Kleb-
siella infection increases the expression levels of Toll-like
receptors 2 and 4 (TLR2 and TLR4) [14]. This increased
expression of TLRs results in an enhancement of the cellu-
lar response upon stimulation with Pam3CSK4 or
lipopolysaccharide, TLR2 and TLR4 agonists, respectively
[14]. In this study, we show for the first time that K. pneu-
moniae exerts a cytotoxic effect on airway epithelial cells
that is associated with the presence of CPS.
Methods
Bacterial strains
K. pneumoniae strains 52145 and 1850 are clinical isolates
belonging to serotypes O1:K2 and O1:K35, respectively
[15]. K. pneumoniae strain 43816 (ATCC 43816) belongs
to serotype O1:K2. K. pneumoniae 52K10 is a derivative of
strain 52145 which lacks CPS [16]. K. pneumoniae strains
were cultured in Luria-Bertani (LB) medium at 37°C.
CPS purification and quantification
Cell-bound CPS was purified by the phenol-water method
[17]. Briefly, bacteria were grown in 1 l LB-broth in 2 l
flasks in an orbital shaker (180 rpm) for 24 h at 37°C.
Cells were removed by centrifugation and washed once
with PBS. The pellet was extracted with phenol, and
polysaccharides present in the aqueous phase were precip-
itated by adding 5 volumes of methanol plus 1% (v/v) of
a saturated solution of sodium acetate in methanol. After
incubation for 24 h at -20°C, the pellet was recovered by
centrifugation, dissolved in distilled water, dialysed
against water and freeze-dried. For further purification,
this preparation was dispersed (final concentration 10
mg/ml) in 0.8% NaCl/0.05% NaN3/0.1 M Tris-HCl (pH
7) and digested with nucleases (50 mg/ml of DNase II
type V and RNase A [Sigma Chemical Co., St. Louis, Mo.])
for 18 h at 37°C. Proteinase K was added (50 mg/ml [E.
Merck, Darmstadt, Germany]), and the mixture was incu-
bated for 1 h at 55°C and for 24 h at room temperature.
The proteinase K digestion was repeated twice and the
polysaccharides were precipitated as described above. The
pellet was recovered by centrifugation and dissolved in
distilled water. LPS was removed by ultracentrifugation
(105000 × g, 16 h, 4°C) and samples were freeze-dried.
The enzymatic treatment and ultracentrifugation steps
were repeated once. This CPS preparation was repurified
by the method described by Hirschfeld and co-workers
[18]. This method is widely used to remove proteins from
polysaccharide preparations. SDS-PAGE-resolved prepa-
rations were transferred to PVDF membrane which was
stained with colloidal gold to visualize proteins [19]. No
trace of contaminant proteins was found (data not
shown). CPS was quantified by determining the concen-
tration of uronic acid in the samples, using a modified car-
bazole assay [20] as described by Rahn and Whitfield [21].
LPS presence was determined by measuring the 3-deoxy-
d-manno-2-octulosonic acid (Kdo) content by the thio-
barbituric acid method modified to correct interference
due to deoxysugars [22]. Kdo content was less than
0.07%.
Mammalian cell culture and bacterial infection
Monolayers of human lung carcinoma cells (A549, ATCC
CCL185) derived from type II pneumocytes were grown to
confluence as described before [13]. Cells were serum
starved for 18 h before infection. Overnight-grown bacte-
ria were subcultured and grown to exponential phase, har-
vested by centrifugation (20 min/2700 × g) and
resuspended in PBS. The inoculum for the infection was
prepared in Earle's buffered salt solution (EBSS), pH 7.4.
A549 cells (80–90% confluent) seeded on glass coverslips
in 24-well tissue culture plates were subsequently infected
with K. pneumoniae strains at a multiplicity of infection
(MOI) ranging from 100:1 to 1000:1 and centrifuged for
4 min at 200 × g at 22°C. Infected plates were then incu-
bated for 2 to 5 h at 37°C/5% CO2 in a humidified incu-
bator. For adhesion assays, cells were washed five times
with 1 ml phosphate-buffered saline (PBS) pH 7.4 after 2
h of infection and lysed with 0.5%-Triton in PBS. Serial
dilutions of the lysates in PBS were plated on LB plates for
quantification of viable bacteria. Experiments were carried
out in triplicate in three independent occasions and
results are expressed as % adhesion = 100 × (n° of bacteria
recovered from well/initial n° of bacteria added). Where
indicated, bacteria were UV killed by exposure to 1 joule
for 3 min in a BIO-LINK BLX crosslinker (Vilber Lour-
mat).Page 2 of 9
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Cell monolayers were fixed in 3.7% paraformaldehyde in
PBS. Rhodamine (RRX)-conjugated phalloidin (Molecu-
lar Probes) diluted 1:200 in 10% horse serum/0.1%
saponin in PBS was used to stain the actin cytoskeleton.
Coverslips were washed twice in PBS containing 0.1%
saponin, once in PBS, and incubated for 30 min with
phalloidin-RRX. The coverslips were then washed twice in
0.1% saponin in PBS, once in PBS and once in H2O,
mounted in Aqua-Poly/Mount (Polysciences) and ana-
lysed with a Leica CTR6000 fluorescence microscope.
Analysis of host cell DNA integrity after K. pneumoniae 
infection
A549 cells were infected with K. pneumoniae strains at
MOI of 500:1 in tissue culture plates. 6 h post-infection,
cells (~2.5 × 106) from 2 wells were collected in PBS by
scraping and lysed in 600 μl cold lysis buffer (10 mM Tris-
HCl pH 8, 1 mM EDTA, 0.1% SDS). Proteinase K (100 μg/
ml) was added and samples were incubated for 3 h at
55°C. Samples were cooled to 22°C and incubated with
20 μg/ml RNase (DNase-free) for 20 min at 37°C. 200 μl
5 M potassium acetate were added and samples were cen-
trifuged (13000 × rpm, 22°C, 1 min). DNA present in the
supernatants was precipitated with isopropanol, washed
in 70% ethanol and dissolved in sterile water. DNA integ-
rity was analysed by staining with ethidium bromide after
resolving the samples by gel-electrophoresis in 1% agar-
ose in TAE.
Cell cytotoxicity and viability assays
A549 cells (cultured in either 24- or 96-well plates) were
infected with K. pneumoniae strains (MOI 500:1 or 1000:1,
5 h). Lactate dehydrogenase (LDH) release was measured
using a commercial kit (CytoTox 96, Promega). Per cent
cytotoxicity was calculated as: (OD490 sample - OD490
medium)/(OD490 max - OD490 medium)*100. OD490 max
was obtained with the provided lysis positive control.
Measure of formazan production from reduction of MTS
tetrazolium by metabolically active cells was performed
using cells cultured in 96-well plates. Formazan produc-
tion (% viability) was measured using a kit (CellTiter 96
AQueous One, Promega) and calculated as: OD490 sam-
ple/OD490 max*100. OD490 max was obtained from a
monolayer of non-infected cells. Ethidium bromide is
taken up by host cells when cytoplasmic membrane integ-
rity is lost, staining nuclei red when visualised by fluores-
cence microscopy. Cells were cultured on coverslips in 24-
well plates and infected as described above (MOI 500:1, 5
h). 15 min before the end of the infection, culture
medium was removed and wells were washed with 1 ml
PBS. Cells were stained for 10 min with 250 μl of 6 TM
ethidium bromide prepared in PBS, washed three times
with 1 ml PBS, fixed with 3.7% paraformaldehyde in PBS,
and mounted for immunofluorescence analysis as
described above. Cytotoxicity (red nuclei) was quantified
by counting a minimum of 100 cells in three independent
experiments.
Mouse pneumonia model
Overnight-grown bacteria were subcultured and grown to
exponential phase. Bacteria were centrifuged (2500 × g, 20
min, 22°C), resuspended in PBS and adjusted to 5 × 106
colony-forming units (c.f.u.)/ml. Five to seven-week-old
female C57BI/6j mice were anaesthetized by i.p. injection
with a mixture containing ketamine (100 mg/ml) and
xylazine (10 mg/ml). 20 μl of bacterial suspension were
inoculated intranasally in 4 × 5 μl aliquots. 48 or 72 h
post-infection the mice were sacrificed by cervical disloca-
tion and trachea, spleen and liver were dissected, weighed
and homogenized in 1 ml PBS. Serial dilutions of the
homogenates in PBS were plated on LB agar to determine
c.f.u. per gram of tissue.
Statistics
Statistical analyses were performed with Prism4 for PC
(GraphPad Software) using the analysis of variance
(ANOVA) or the two-sample t test or, when the require-
ments were not met, by the Mann-Whitney U test. P < 0.05
was considered statistically significant.
Results
K. pneumoniae induces a cytotoxic effect in lung 
epithelial cells
A549 lung epithelial cells were infected with K. pneumo-
niae 52145 (52145), a highly capsulated strain (339 μg
per 105 c.f.u.) for 5 h with different MOIs and the host
actin cytoskeleton was stained. This is a sensitive method
to detect whether a pathogen induces cytoskeleton distur-
bances which can be associated with host cell cytotoxicity
[23]. Actin cytoskeleton staining revealed that cells
rounded up at MOI 500:1 (Fig. 1A), followed by detach-
ment from the substrate. At MOI 1000:1 a cytotoxic effect
on the cell monolayer was observed (white arrows and
detail). To determine the minimal infection requirements
for cell rounding, cells were infected with different MOIs
for 2 to 5 h. Cell rounding was observed when cells were
infected at MOI 500:1 for 4 h (Fig. 1B, top). To investigate
whether the cytotoxic effect was strain dependent two
additional K. pneumoniae strains were tested. Strains
43816 (serotype K2) and 1850 (serotype K35) also
induced cell rounding (Fig. 1B, middle and bottom,
respectively). CPS amounts expressed by these strains, 238
and 35 μg per 105 c.f.u., respectively, are lower than that
expressed by strain 52145 (339 μg per 105 c.f.u.), indicat-
ing that Klebsiella-induced cytotoxicity is not absolutely
dependent on the amount of CPS expressed.
Next, we asked whether live bacteria are necessary to
induce cell rounding. The bacterial inoculum was killedPage 3 of 9
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Under these conditions, strain 52145 did not induce cell
rounding (Fig. 1C, upper). In order to corroborate this
observation, a mock infection was carried out, i.e. same
infection conditions as before, but in a tissue culture well
without cells. After 4 h, the bacterial suspension was UV
irradiated and used to infect a confluent cell monolayer
for 4 h. Cell rounding was not observed (Fig. 1C, middle).
In addition, the strain 52145-triggered cytotoxic effect was
not induced by primed bacteria-free conditioned
medium, since A549 monolayers remained intact after 4
h of exposure to bacteria-free medium obtained from pre-
viously infected cells (MOI 500:1, 4 h) (Fig. 1C, lower).
Taken together, these findings demonstrate that K. pneu-
moniae strain 52145 induces a cytotoxic effect through a
process requiring the presence of live bacteria.
K. pneumoniae-induced cytotoxicity is dependent on the 
presence of CPS
We sought to pinpoint bacterial factor(s) responsible for
strain 52145-triggered cytotoxicity. Taken into account
that several studies have demonstrated the important role
of CPS in the interplay between K. pneumoniae and eukary-
otic host cells, we asked whether CPS might play a role in
the Klebsiella-induced cytotoxicity. We studied whether an
isogenic CPS mutant of 52145, strain 52K10 [16], would
induce cytotoxicity. Immunofluorescence analysis of the
actin cytoskeleton of infected A549 cells showed that
strain 52K10 did not induce cytotoxicity under all condi-
K. pneumoniae triggers a cytotoxic effect during infection of A549 carcinoma lung epithelial cellsFigure 1
K. pneumoniae triggers a cytotoxic effect during infection of A549 carcinoma lung epithelial cells. A. Infection of 
A549 lung epithelial cells with K. pneumoniae 52145. MOIs used were 200:1 (top), 500:1 (middle) and 1000:1 (bottom panel and 
detail). Infections were carried out for 5 h in all cases. Non infected cells are shown for comparison (top left). Cells were fixed 
and stained for immunofluorescence. Actin cytoskeleton was labelled with phalloidin-RRX (red). White arrows show cell 
rounding and cytotoxicity. B. A549 epithelial cells were infected with K. pneumoniae strains 52145, 43816 and 1850 at MOI 
500:1 for 4 h. Infected cells were fixed and stained with phalloidin-RRX for immunofluorescence as indicated above. C. UV 
killed K. pneumoniae 52145 was used to infect cells at MOI 500:1 during 4 h (top). K. pneumoniae 52145 was used for a mock 
infection (MOI 500:1). After 4 h the bacterial suspension was UV irradiated and used to infect a confluent cell monolayer for 4 
h (middle). To assess the need of presence of live bacteria to induce cell rounding, infection was carried out at MOI 500:1 dur-
ing 4 h, after which the supernatant was collected, centrifuged and filtered (0.2 Tm, nitrocellulose) to obtain a primed bacteria-
free medium, which was then added to a new epithelium monolayer for 4 h (bottom). Infected cells were fixed and stained for 
immunofluorescence as described above.
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bacterial factors involved in 52145-triggered cytotoxicity
(Fig. 2A). Furthemore, the lack of cytotoxicity during
52K10 infection was not due to a decrease in bacterial
adhesion levels because 52K10 adhesion levels to A549
cells were actually higher than those displayed by CPS-
expressing strains (Fig. 2B). Even though cytotoxicity by
non-capsulated strain was at some extent promoted by
addition of purified CPS during infection, purified CPS
alone did not trigger a cytotoxic effect (data not shown),
suggesting that additional bacterial elements besides CPS
may contribute to cytotocixity during K. pneumoniae infec-
tion.
To further characterize the cytotoxic effect induced by
52145, cell toxicity was assessed by four independent
methods: (i) lactate dehydrogenase (LDH) release, (ii)
production of formazan, (iii) analysis of DNA integrity,
and (iv) uptake of ethidium bromide. LDH release, taken
as an indicator of host cell membrane integrity and cell
Capsule polysaccharide (CPS) is required for cytotoxicity during K. pneumoniae infection of A549 lung epitheliumFigure 2
Capsule polysaccharide (CPS) is required for cytotoxicity during K. pneumoniae infection of A549 lung epithe-
lium. A. Infection of A549 lung epithelial cells with K. pneumoniae 52K10, a bacterial strain lacking CPS. MOIs used were 200:1 
(upper), 500:1 (middle) and 1000:1 (lower panel and right detail). Infections were carried out for 5 h in all cases. Infection con-
ditions of MOI 500:1 for 4 h were used in the bottom panel. Infected cells were fixed and stained for immunofluorescence. 
Actin cytoskeleton was labelled with phalloidin-RRX (red). White arrows and detail show cell spread morphology and absence 
of cytotoxicity. B. Adhesion levels of K. pneumoniae strains 52145 and 52K10 to A549 lung epithelial cells. Infections were car-
ried out at MOI 100:1 for 2 h. Mean values from three independent experiments are shown (error bars = SD).
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with strains 52145 or 52K10, and compared to that
released by non-infected cells (see Methods section). K.
pneumoniae strain 52145 (MOI 500:1, 5 h) triggered 30.2
± 0.28% cytotoxicity, which was approximately 1.5 times
higher than that induced by strain 52K10 (20.2 ± 2.19%).
Formazan is produced by reduction of MTS tetrazolium
by metabolically active cells and thus serves as an indica-
tor of cell viability. Formazan production (% viability)
was lower in strain 52145-infected cells (32.9 ± 6.5%)
than in non-infected (100%) or 52K10-infected cells (134
± 4.9%). DNA fragmentation is taken as a sign of cell
death by apoptosis. A prominent DNA laddering/degrada-
tion could be seen after 6 h of infection with K. pneumo-
niae strains 52145, 43816 and 1850 (Fig. 3A). However,
DNA extracted from cells infected with strain 52K10 was
intact, similar to DNA obtained from non-infected cells
(Fig. 3A). Finally, we analysed the uptake of ethidium bro-
mide by infected cells. Ethidium bromide is taken up by
the cells only when integrity of the plasma membrane is
lost. Red fluorescence staining of nuclei is therefore an
indicator of plasma membrane integrity loss. The percent-
age of cells which had taken up the dye was higher in
52145-infected cells (21.2 ± 2.2%) than in 52K10-
infected cells (1.74 ± 0.9%) or in non-infected cells (0%).
Representative pictures are shown in Fig. 3B.
In summary, these findings indicate that K. pneumoniae
alters host cell viability in a process dependent on the
presence of CPS.
Correlation between K. pneumoniae-induced cell 
cytotoxicity and virulence
It is well known that CPS is essential for K. pneumoniae-
induced pneumonia [16] and we have established here
that Klebsiella-induced cytotoxicity depends on the pres-
ence of CPS. We sought then to determine whether induc-
tion of cytotoxicity is sufficient for K. pneumoniae
virulence using an intranasal model of infection. As an
infection marker, we determined the bacterial loads in
lung, liver and spleen for K. pneumoniae strains 52145,
43816, 1850. Strain 52145 successfully infected mouse
lungs (Fig. 4A and 4B, left) and disseminated to liver (Fig.
4A and 4B, middle) and spleen (Fig. 4A and 4B, right). No
decrease in the bacterial load, which was higher in lung
than in liver and spleen, was observed in any organ at 72
h post-infection. Strains 43816 and 1850, both inducing
cytotoxicity, displayed an intermediate virulence pheno-
type. Strain 43816 was detected in lungs, with similar
recovery at 48 and 72 h post-infection. Systemic infection
was delayed until 72 h post-infection. Strain 1850 was
equally recovered from lungs at 48 and 72 h post-infec-
tion. Spleen and liver colonization were hardly observed
at any time. As a control, we determined the bacterial
loads in lung, liver and spleen of the CPS mutant strain
Klebsiella induced cytotoxicity is observed by disintegration of host genomic DNA and loss of host plasma membrane integrityFigure 3
Klebsiella induced cytotoxicity is observed by disintegration of host genomic DNA and loss of host plasma 
membrane integrity. A. Ethidium bromide staining after agarose gel-electrophoresis of genomic DNA isolated from A549 
epithelial cells infected with K. pneumoniae strains 52145, 43816, 1850 or 52K10. B. A549 lung epithelial cells were not infected 
(left), infected with K. pneumoniae strain 52K10 (middle), or strain 52145 (right). The cells were stained with ethidium bromide 
and analysed by fluorescence microscopy. Necrotic or apoptotic cells had normal/condensed nuclei that were brightly stained 
with ethidium bromide and appeared red (white arrows).
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attenuated. Viable counts recovered from lung were signif-
icantly lower than those for capsulated strains at 48 and
72 h post-infection and bacteria could not be recovered
from liver or spleen at any time post-infection.
Therefore, although cytotoxicity is likely to be associated
with virulence, strains expressing different capsule levels
were not equally virulent, suggesting that additional bac-
terial factors could be involved in virulence, or that the
cytotoxic effect is necessary, but not sufficient, for viru-
lence.
Discussion
In this study, we show that K. pneumoniae triggers a cyto-
toxic effect upon infection of human lung epithelial cells.
This process requires the presence of capsulated live bac-
teria through the time of infection. To the best of our
knowledge, there are no studies reporting that K. pneumo-
niae might exert a cytotoxic effect on airway epithelial
cells. Our results could point to the underlying mecha-
nism behind the early findings reported by Straus et al.,
[5,24] which indicated that K. pneumoniae expressing CPS
induces extensive lung tissue damage.
A number of bacterial pathogens induce cytotoxicity in
eukaryotic cells, which is frequently dependent on an
active type IIIsecretion system (T3SS). For example, enter-
opathogenic Escherichia coli induces detachment of
infected epithelial cells from the substratum and injects
the T3SS effector Cif into cells, which induces a cytopathic
effect [25,26]. Bordetella bronchiseptica's necrotic effect on
epithelial cells is dependent on the T3SS effector BopB
[27], and also Pseudomonas aeruginosa promotes T3SS-
dependent cytotoxicity towards eukaryotic cells [28,29].
Yet, K. pneumoniae-induced cytotoxicity does not seem to
be related to a T3SS, given that in silico analysis of the so
far sequenced K. pneumoniae genomes does not identify
Mouse pneumonia model for K. pneumoniae strainsFig re 4
Mouse pneumonia model for K. pneumoniae strains. Intranasal infections by K. pneumoniae strains 52145, 43816, 1850 
and 52K10. Mice were infected with 105 c.f.u. and sacrificed 48 h (A) or 72 h (B) post-infection. Lung, spleen and liver were 
dissected, weighed, homogenized and plated on LB agar. Data shown are from five infected mice per time point. Mean values 
are plotted.
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degenerated primers to amplify lcrD homologues present
in all known T3SS were negative in all our Klebsiella
strains. Recently, it has been shown that P. aeruginosa and
enterotoxigenic E. coli deliver toxins directly into host cell
cytoplasm using outer membrane vesicles [30,31]. It is
likely that K. pneumoniae also produces outer membrane
vesicles. In fact, the extracellular toxic complex described
by Straus [5,24] could be considered a preparation of
outer membrane vesicles. It is then tempting to speculate
that outer membrane vesicles could be associated with K.
pneumoniae cytotoxicity described in our study. Future
studies will aim to address this possibility. On the other
hand, our results clearly establish that CPS is necessary for
the induction of cytotoxicity. CPS is a virulence factor for
several pathogens, including Streptococcus pneumoniae,
Neisseria meningitidis, Haemophilus influenzae type b and E.
coli K1 [32-34]. Of note, no previous reports link the pres-
ence of CPS to cytotoxicity. However, just the presence of
CPS is not sufficient for K. pneumoniae-induced cytotoxic-
ity because capsulated UV-killed bacteria or purified CPS
did not induce this effect. Given the limited current
knowledge about K. pneumoniae virulence factors, we can
only speculate on the nature of bacterial factor(s) that,
together with CPS, could promote cytotoxicity in the host.
Signature-tagged mutagenesis approaches have identified
several virulence factors [35,36], but none of them resem-
ble those triggering the cytotoxicity by other bacterial
pathogens.
All K. pneumoniae clinical isolates are capsulated, inferring
the importance of CPS for virulence. Likewise, CPS is nec-
essary for virulence in an in vivo pneumonia model
[15,35] and for Klebsiella-induced cytotoxicity (this work).
However, our data indicate that CPS-dependent cytoxicity
is necessary but not sufficient for Klebsiella virulence
because strains 43816 and 1850 are less virulent than
strain 52145 and the three of them trigger cytotoxicity.
This could be explained by differences in the amount of
CPS expressed by these strains, although strain 43816 is
also considered to be heavily capsulated. The absence of
complete correlation between in vitro and in vivo studies
has been previously described for other K. pneumoniae iso-
lates. Struve et al., showed that CPS expression reduced K.
pneumoniae adhesion to gut and bladder epithelium,
when compared to a noncapsulated mutant. However, the
presence/absence of CPS had no effect on the colonisation
of the gastrointestinal tract, but did play a role in coloni-
sation of the urinary tract [37]. On the other hand, it has
been recently postulated that there is an association
between CPS serotype, virulence in mice and humans,
and frequency of isolation in clinical settings [38]. How-
ever, the bacterial strains tested in this study express CPS
belonging to serotypes considered to have high potential
of causing disease [38], and strains 52145 and 43816
express the same CPS serotype. Nevertheless, Klebsiella
infections should be looked at as the outcome of specific
interactions between pathogen and host cells. Indeed, fac-
tors on both pathogen and host sides may be involved in
the progression of the infection. In this context, it is
widely accepted that host innate immunity plays a key
role to clear K. pneumoniae infections. Therefore, differ-
ences among strains in the resistance to complement and/
or to antimicrobial peptides mediated killing may
account for differences in virulence [11,15,39]. In addi-
tion, a wealth of evidence clearly indicates the importance
of the inflammatory responses in clearing K. pneumoniae
infection and have provided substantial evidence for the
protective role of a Th1-mediated response [40-42]. Thus,
differences in the induction of inflammatory responses
among strains may also underline in vivo behavior. In
summary the available data support the notion that CPS-
dependent cytotoxicity, together with other bacterially
triggered events, is required for virulence. Further studies
will attempt to elucidate these novel virulence mecha-
nisms, which may differ among capsulated strains, in
order to achieve a comprehensive understanding of K.
pneumoniae pathogenesis.
Conclusion
This study allocates a novel role to K. pneumoniae capsule,
i.e. the induction of cytotoxicity during the infection of
lung epithelial cells. This effect, which has been analysed
by using four different approaches, is not capsule serotype
dependent, does require the presence of live bacteria, and
does not seem to be directly related to bacterial adhesion.
Host cell cytotoxicity could be associated with virulence.
However, strains expressing different capsule levels were
not equally virulent, suggesting that additional bacterial
elements could be involved in Klebsiella virulence.
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